Osteosarcoma (OS), a prevalent aggressive malignancy in the bone, has limited therapeutic targets and diagnostic biomarkers. In the current investigation, RT-qPCR showed that CDKN2B-AS1 was enhanced in OS samples and cells. This research was set to examine the modulation of CDKN2B-AS1 in OS. The expression of CDKN2B-AS1 and downstream molecules was analyzed by RT-qPCR method. CCK8, EdU staining along with Transwell assays were applied to evaluate cell proliferation and invasion. Those investigations specified that silencing of CDKN2B-AS1 with shRNAs obviously impeded the proliferation and invasion of MG63 cells. To authenticate the relationships between CDKN2B-AS1 and microRNA-122-5p (miR-122-5p) or cyclin G1 (CCNG1) and miR-122-5p, we next employed luciferase reporter assay. We displayed that CDKN2B-AS1 repressed miR-122-5p to restore CCNG1 expression. All in all, our findings substantiated the indispensable function of CDKN2B-AS1 in OS progression and the possible molecular mechanism.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/10799893.2020.1850784 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Six genetic variants are associated with cardiovascular disease independently from canonical risk factors: a new method to refine GWAS results based on the UKBiobank phenotype database.
Mol Genet Genomics
December 2024
Department of Health Promotion, Maternal and Child Care, Internal Medicine and Medical Specialities "G. D'Alessandro" (PROMISE), University of Palermo, Via del Vespro 129, Palermo, 90127, Italy.
This paper describes a novel methodology based on GWAS filtering, aimed to find novel phenotypes associated to genetic loci independently of canonical risk factors using the large database of UK Biobank. Genome wide association studies (GWAS) is an untargeted methodology able to identify novel gene variants associated with diseases. Novel gene-phenotype associations might be discovered by this method.
View Article and Find Full Text PDFThe mechanisms of Chr.9p21.3 risk locus in coronary artery disease - where are we today?
Am J Physiol Heart Circ Physiol
December 2024
A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland. Kuopio, Finland.
Despite the advancements and release of new therapeutics in the past few years, cardiovascular diseases (CVDs) have remained the number one cause of death worldwide. Genetic variation of a 9p21.3 genomic locus has been identified as the most significant and robust genetic CVD risk marker on the population level, with the strongest association with coronary artery disease (CAD) and other diseases, including diabetes and cancer.
View Article and Find Full Text PDFAssociations of the Expression Levels and Risk Variants of CDKN2B-AS1 Long Noncoding RNA With the Susceptibility and Progression of Prostate Cancer.
J Cell Mol Med
December 2024
Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Article Synopsis
Causal relationships of familial hypercholesterolemia with the risk of multiple vitamin deficiencies: a Mendelian randomization study.
Front Endocrinol (Lausanne)
November 2024
National Drug Clinical Trial Center, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
Article Synopsis
- This study explores the connection between familial hypercholesterolemia (FH) and vitamin deficiencies, seeking to clarify if having FH increases the risk of these deficiencies.
- Utilizing Mendelian randomization, researchers analyzed extensive datasets from the FinnGen study, focusing on FH, ischemic heart disease, and various vitamin levels among over 300,000 individuals.
- The findings suggest that FH is linked to higher odds of thiamine and vitamin D deficiencies, highlighting potential complications arising from FH that may impact individuals' health.
Amlodipine increases risk of primary open-angle glaucoma.
Clin Hypertens
November 2024
Severn Health Solutions, Severna Park, MD, USA.
Article Synopsis
- Calcium channel blockers, specifically amlodipine, have been found to increase the risk of developing primary open-angle glaucoma (POAG) by 23%, prompting a study to further explore this association and its genetic factors.
- An analysis using MedWatch and UK Biobank data revealed that amlodipine use was linked to a significant rise in POAG prevalence and identified specific genetic polymorphisms (GAS7, CDKN2B-AS1, SIX6) that contribute to this risk.
- The study concluded that while amlodipine is commonly used for hypertension, its potential connection to POAG emphasizes the need for healthcare providers to consider alternative medications to minimize this risk.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!